MedTrace Logo

Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis

NCT06289452 · Status: ACTIVE_NOT_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2025-04-30

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the safety and efficacy of IVB102 injection in subjects with XLRS.

Conditions

  • Retinoschisis
  • Retinal Disease
  • Retinal Degeneration
  • Eye Diseases

Interventions

GENETIC

IVB102 Injection

Gene transfer by intravitreal injection of the RS1 AAV vector

GENETIC

IVB102 Injection

Gene transfer by intravitreal injection of the RS1 AAV vector

GENETIC

IVB102 Injection

Gene transfer by intravitreal injection of the RS1 AAV vector

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER

  • InnoVec Biotherapeutics Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
8 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-08
Primary Completion
2025-12-31
Completion
2029-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06289452 on ClinicalTrials.gov